Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Outcome Measure:

43 women in the follow-up group, 44.1% experienced spontaneous regression, 20.9% had partial regression, 23.2% progressed to CIN3, and 11.6% showed persistence. 44 women whose lesion was excised, the regression rate was 90.9%

Outcome Time Frame:

12 months

Safety Issue:

Yes

Principal Investigator

Sylvia F Brenna, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universidade Cidade de Sao Paulo

Authority:

Brazil: Ethics Committee

Study ID:

CIN 2

NCT ID:

NCT00733109

Start Date:

March 2003

Completion Date:

July 2007

Related Keywords:

• Cervical Intraepithelial Neoplasia
• CIN2
• management
• Neoplasms
• Cervical Intraepithelial Neoplasia
• Uterine Cervical Dysplasia
• Carcinoma in Situ

Name	Location